Insurers pay more for multiple sclerosis drug because rebates don’t help, report says
(By Ed Silverman for STAT) Drug makers may offer rebates to payers, but health plans continue to see notable increases
Read More
Skeptics Question The Value Of Hydration Therapy For The Healthy
(By Taunya English for NPR) Yana Shapiro is a partner at a Philadelphia law firm, has an exhausting travel schedule
Read MoreYou Can Monitor Your Heart With A Smartphone. But Should You?
(By Erin Ross for NPR) Digital gizmos can monitor your heart, whether it’s a wrist-worn fitness tracker or a smartphone
Read MoreThe Road Ahead for Social Security–A Summation of the Situation
The long-term dilemma faced by the Social Security and Medicare Trust Funds is not a self-correcting situation, and most Americans
Read MoreWaste from pharmaceutical plants in India and China promotes antibiotic-resistant superbugs
(By Henry A. Waxman and Bill Corr for STAT) Superbugs, disease-causing microbes that have mutated to become resistant to antibiotics,
Read MoreThe insulin market is heading for a shakeup. But patients may not benefit
(By Rebecca Robbins for STAT) The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of
Read MoreWhy Is The News About TB So Bad?
(By Rina Shalkh-Lasko for NPR) Many countries think of TB as a disease of the past and this lack of
Read MoreOfficials Warn Some Older Marketplace Customers To Switch To Medicare
(By Susan Jaffe for Kaiser Health News) Ever since the Affordable Care Act’s health insurance marketplaces opened for business in
Read MoreThe ‘Swiss Agent’: Long-forgotten research unearths new mystery about Lyme disease
(By Charles Piller for STAT) The tick hunter was hopeful he had found the cause of the disabling illness, recently
Read MoreOpen Enrollment–Time to Re-Check Your Drug Coverage
The annual Medicare Open Enrollment period, which runs through December 7, provides an opportunity to re-examine your Part D drug
Read More